BRINGSPRING SCIENCE AND TECHNOLOGY CO., LTD. Financials Bringspring Science and Technology Co., Ltd.
Equities
300290
CNE100001C30
IT Services & Consulting
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.74 CNY | +3.20% |
|
-5.03% | +27.09% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,998 | 3,522 | 2,886 | 4,449 | 2,883 | 3,901 |
| Enterprise Value (EV) 1 | 1,916 | 3,393 | 2,663 | 4,199 | 2,672 | 3,655 |
| P/E ratio | 96.2 x | 80.1 x | 34.6 x | -10.6 x | -12.8 x | 147 x |
| Yield | 0.2% | 0.25% | 0.54% | - | - | - |
| Capitalization / Revenue | 3.19 x | 4.87 x | 3.66 x | 5.44 x | 4.09 x | 4.89 x |
| EV / Revenue | 3.06 x | 4.69 x | 3.38 x | 5.14 x | 3.79 x | 4.58 x |
| EV / EBITDA | 50 x | 45 x | 22.1 x | -42.2 x | -38.3 x | 76.5 x |
| EV / FCF | 21.7 x | -35.1 x | 216 x | -342 x | -198 x | 311 x |
| FCF Yield | 4.61% | -2.85% | 0.46% | -0.29% | -0.5% | 0.32% |
| Price to Book | 2.25 x | 3.23 x | 2.11 x | 4.29 x | 3.56 x | 4.72 x |
| Nbr of stocks (in thousands) | 507,859 | 553,757 | 597,528 | 639,238 | 640,558 | 640,558 |
| Reference price 2 | 3.933 | 6.360 | 4.830 | 6.960 | 4.500 | 6.090 |
| Announcement Date | 4/24/19 | 4/28/20 | 4/23/21 | 4/28/22 | 4/20/23 | 4/23/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 626.7 | 723.8 | 787.9 | 817.3 | 705.1 | 797.5 |
| EBITDA 1 | 38.31 | 75.39 | 120.7 | -99.55 | -69.85 | 47.76 |
| EBIT 1 | 17.26 | 49.82 | 91.2 | -112.6 | -76.76 | 35.55 |
| Operating Margin | 2.75% | 6.88% | 11.57% | -13.78% | -10.89% | 4.46% |
| Earnings before Tax (EBT) 1 | 24.31 | 46.11 | 95.17 | -349.5 | -209.6 | 48.43 |
| Net income 1 | 20.42 | 43.15 | 80.37 | -404.8 | -225.2 | 26.54 |
| Net margin | 3.26% | 5.96% | 10.2% | -49.53% | -31.94% | 3.33% |
| EPS 2 | 0.0409 | 0.0794 | 0.1395 | -0.6538 | -0.3528 | 0.0415 |
| Free Cash Flow 1 | 88.36 | -96.68 | 12.35 | -12.26 | -13.48 | 11.75 |
| FCF margin | 14.1% | -13.36% | 1.57% | -1.5% | -1.91% | 1.47% |
| FCF Conversion (EBITDA) | 230.63% | - | 10.23% | - | - | 24.6% |
| FCF Conversion (Net income) | 432.63% | - | 15.36% | - | - | 44.26% |
| Dividend per Share 2 | 0.008000 | 0.0160 | 0.0263 | - | - | - |
| Announcement Date | 4/24/19 | 4/28/20 | 4/23/21 | 4/28/22 | 4/20/23 | 4/23/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 81.3 | 129 | 223 | 250 | 210 | 246 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 88.4 | -96.7 | 12.3 | -12.3 | -13.5 | 11.7 |
| ROE (net income / shareholders' equity) | 2.69% | 4.47% | 7.56% | -31.6% | -22.1% | 4.35% |
| ROA (Net income/ Total Assets) | 0.85% | 2.03% | 3.18% | -3.65% | -2.82% | 1.46% |
| Assets 1 | 2,390 | 2,126 | 2,525 | 11,096 | 7,986 | 1,814 |
| Book Value Per Share 2 | 1.750 | 1.970 | 2.290 | 1.620 | 1.270 | 1.290 |
| Cash Flow per Share 2 | 0.3900 | 0.5200 | 0.6400 | 0.6500 | 0.4500 | 0.4300 |
| Capex 1 | 19.6 | 30.9 | 30.9 | 63.4 | 48.5 | 19.5 |
| Capex / Sales | 3.12% | 4.27% | 3.92% | 7.76% | 6.88% | 2.44% |
| Announcement Date | 4/24/19 | 4/28/20 | 4/23/21 | 4/28/22 | 4/20/23 | 4/23/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +27.09% | 686M | |
| -13.48% | 191B | |
| +1.53% | 167B | |
| +3.37% | 155B | |
| +8.31% | 103B | |
| +35.49% | 83.67B | |
| +11.19% | 82.06B | |
| -6.43% | 71.79B | |
| -18.66% | 54.05B | |
| -8.68% | 43.34B |
- Stock Market
- Equities
- 300290 Stock
- Financials Bringspring Science and Technology Co., Ltd.
